Synaps LLC is a Washington, DC-based company specializing in venture capital investment, science technology proposal review, and aerospace research. With over 15 years of experience, they provide guidance to their clients in securing federal and private funding, as well as informing investment decisions for their VC teaming partners. Their expertise spans various sectors, including biomedical technologies, biosurveillance, diagnostics, and therapeutic discovery.
Located just blocks away from the White House and government agencies, Synaps LLC is well-positioned to compete for federal contracts and collaborate with clients in Washington, D.C. and beyond. Their team, led by President and CEO Dr. Robert Caldwell, brings extensive knowledge in infectious diseases, cancer metastasis, and bone metabolic diseases. With a focus on national security, technology assessment, and research allocation, Synaps LLC plays a vital role in advancing scientific innovation and translating it into value for their clients worldwide.
Generated from the website